#kymr — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #kymr, aggregated by home.social.
-
Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration
First-in-human Phase 1 trial evaluating KT-485 (SAR447971) initiated, triggering a $20 million milestone payment from Sanofi Xw-V46t3ppW-m0Vg8loC2rrmMOcGpekzm0rXj6c0nkCxRad_A_U=” target=”_blank”…
#France #FR #Europe #EU #Sanofi #kymera-therapeutics-inc #kymr #life-science-investing #nasdaq-kymr
https://www.europesays.com/france/33775/